GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » Earnings Yield (Joel Greenblatt) %

ClouDr Group (HKSE:09955) Earnings Yield (Joel Greenblatt) % : -9.62% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group Earnings Yield (Joel Greenblatt) %?

ClouDr Group's Enterprise Value for the quarter that ended in Dec. 2023 was HK$3,597 Mil. ClouDr Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-346 Mil. ClouDr Group's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was -9.62%.

The historical rank and industry rank for ClouDr Group's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

HKSE:09955' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -146.1   Med: -77.41   Max: -12.14
Current: -20.7

During the past 5 years, the highest Earnings Yield (Joel Greenblatt) of ClouDr Group was -12.14%. The lowest was -146.10%. And the median was -77.41%.

HKSE:09955's Earnings Yield (Joel Greenblatt) % is ranked worse than
95.05% of 101 companies
in the Medical Distribution industry
Industry Median: 5.91 vs HKSE:09955: -20.70

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. ClouDr Group's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


ClouDr Group Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for ClouDr Group's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group Earnings Yield (Joel Greenblatt) % Chart

ClouDr Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Earnings Yield (Joel Greenblatt) %
- - - -25.58 -9.62

ClouDr Group Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial - - -25.58 - -9.62

Competitive Comparison of ClouDr Group's Earnings Yield (Joel Greenblatt) %

For the Medical Distribution subindustry, ClouDr Group's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ClouDr Group's Earnings Yield (Joel Greenblatt) % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, ClouDr Group's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where ClouDr Group's Earnings Yield (Joel Greenblatt) % falls into.



ClouDr Group Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

ClouDr Groups Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-346.229/3596.7493
=-9.63 %

For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.



ClouDr Group  (HKSE:09955) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


ClouDr Group Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of ClouDr Group's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


ClouDr Group (HKSE:09955) Business Description

Industry
Traded in Other Exchanges
Address
No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its offerings include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

ClouDr Group (HKSE:09955) Headlines

No Headlines